News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Bonstein Sara
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/08/2023 |
4
| Bonstein Sara (Director) has filed a Form 4 on scPharmaceuticals Inc.|
Txns:
| Granted 17,300 options to buy
@ $11.71, valued at
$202.6k
|
|
| 05/17/2023 |
4
| Bonstein Sara (CFO) has filed a Form 4 on INSMED Inc|
Txns:
| Sold 2,210 shares
@ $19.3, valued at
$42.7k
Sold 1,610 shares
@ $18.47, valued at
$29.7k
|
|
| 01/12/2023 |
4
| Bonstein Sara (CFO) has filed a Form 4 on INSMED Inc|
Txns:
| Sold 2,857 shares
@ $18.12, valued at
$51.8k
|
|
| 01/06/2023 |
4
| Bonstein Sara (CFO) has filed a Form 4 on INSMED Inc|
Txns:
| Granted 8,232 shares
@ $0
Granted 5,065 shares
@ $0
Granted 37,760 options to buy
@ $19.74, valued at
$745.4k
|
|
| 06/17/2022 |
4
| Bonstein Sara (Director) has filed a Form 4 on Xilio Therapeutics, Inc.|
Txns:
| Granted 13,200 options to buy
@ $2.28, valued at
$30.1k
|
|
| 06/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/13/2022 |
4
| Bonstein Sara (CFO) has filed a Form 4 on INSMED Inc|
Txns:
| Sold 1,154 shares
@ $25.11, valued at
$29k
|
|
| 01/10/2022 |
4
| Bonstein Sara (CFO) has filed a Form 4 on INSMED Inc|
Txns:
| Granted 13,006 shares
@ $0
Granted 62,840 options to buy
@ $26.43, valued at
$1.7M
|
|
| 06/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/13/2020 |
4
| Bonstein Sara (Director) has filed a Form 4 on scPharmaceuticals Inc.|
Txns:
| Granted 12,248 options to buy
@ $8.23, valued at
$100.8k
|
|
| 05/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/05/2020 |
4
| Bonstein Sara (CFO) has filed a Form 4 on INSMED Inc|
Txns:
| Granted 91,640 options to buy
@ $28.88, valued at
$2.6M
|
|
| 01/21/2020 |
4
| Bonstein Sara (CFO/COO) has filed a Form 4 on ONCOSEC MEDICAL Inc|
Txns:
| Sold 1,351 shares
@ $2.08, valued at
$2.8k
|
|
| 10/18/2019 |
4
| Bonstein Sara (CFO/COO) has filed a Form 4 on ONCOSEC MEDICAL Inc|
Txns:
| Sold 1,111 shares
@ $2.01, valued at
$2.2k
|
|
| 07/18/2019 |
4
| Bonstein Sara (CFO/COO) has filed a Form 4 on ONCOSEC MEDICAL Inc|
Txns:
| Paid exercise price by delivering 1,111 shares
@ $2.42, valued at
$2.7k
|
|
| 04/18/2019 |
4
| Bonstein Sara (CFO/COO) has filed a Form 4 on ONCOSEC MEDICAL Inc|
Txns:
| Paid exercise price by delivering 11,102 shares
@ $0.6001, valued at
$6.7k
|
|
| 01/18/2019 |
4
| Bonstein Sara (CFO/COO) has filed a Form 4 on ONCOSEC MEDICAL Inc|
Txns:
| Paid exercise price by delivering 13,379 shares
@ $0.685, valued at
$9.2k
|
|
| 12/27/2018 |
4
| Bonstein Sara (CFO/COO) has filed a Form 4 on ONCOSEC MEDICAL Inc|
Txns:
| Granted 165,000 options to buy
@ $0.6, valued at
$99k
|
|
| 10/18/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/18/2018 |
4
| Bonstein Sara (CFO/COO) has filed a Form 4 on ONCOSEC MEDICAL Inc|
Txns:
| Granted 625,000 shares
@ $0
Paid exercise price by delivering 135,485 shares
@ $1.34, valued at
$181.5k
|
|
| 04/03/2018 |
4
| Bonstein Sara (CFO) has filed a Form 4 on Advaxis, Inc.|
Txns:
| Granted 1,088 shares
@ $1.69, valued at
$1.8k
|
|
| 02/02/2018 |
4
| Bonstein Sara (CFO) has filed a Form 4 on Advaxis, Inc.|
Txns:
| Granted 580 shares
@ $2.96, valued at
$1.7k
|
|
| 01/03/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/04/2017 |
4
| Bonstein Sara (CFO) has filed a Form 4 on Advaxis, Inc.|
Txns:
| Granted 856 shares
@ $2.99, valued at
$2.6k
|
|
| 11/06/2017 |
4
| Bonstein Sara (CFO) has filed a Form 4 on Advaxis, Inc.|
Txns:
| Sold 3,862 shares
@ $3.3, valued at
$12.7k
Granted 100,000 options
@ $3.19, valued at
$319k
|
|
| 11/02/2017 |
4
| Bonstein Sara (CFO) has filed a Form 4 on Advaxis, Inc.|
Txns:
| Granted 379 shares
@ $3.4, valued at
$1.3k
Sold 12,734 shares
@ $3.19, valued at
$40.6k
|
|
| 10/02/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/20/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|
|